[REFERENCES]
1. Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and
intestinal lymphomas and other cancers. Gastroenterology. 2005 Apr;128(4
Suppl 1):S79-86. 2. Rawla P, Barsouk A. Epidemiology of gastric cancer:
global trends, risk factors and prevention. Przeglad Gastroenterol.
2019;14(1):26–38. 3. Loehr WJ, Mujahed Z, Zahn FD, Gray GF,
Thorbjarnarson B. Primary lymphoma of the gastrointestinal tract: a
review of 100 cases. Ann Surg. 1969 Aug;170(2):232–8. 4. Sapkota S,
Shaikh H. Non-Hodgkin Lymphoma. In: StatPearls. Treasure Island (FL):
StatPearls Publishing; 2024. 5. GOUGH KR, READ AE, NAISH JM. Intestinal
reticulosis as a complication of idiopathic steatorrhoea. Gut. 1962
Sep;3(3):232–9. 6. Smedby KE, Akerman M, Hildebrand H, Glimelius B,
Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of
increased risks for lymphoma types other than enteropathy-type T cell
lymphoma. Gut. 2005 Jan;54(1):54–9. 7. Hong YS, Woo YS, Park G, Lee K,
Kang SH, Lee HW, et al. Endoscopic Findings of Enteropathy-Associated
T-Cell Lymphoma Type II: A Case Series. Gut Liver. 2016
Jan;10(1):147–51. 8. Peters U, Askling J, Gridley G, Ekbom A, Linet M.
Causes of death in patients with celiac disease in a population-based
Swedish cohort. Arch Intern Med. 2003 Jul 14;163(13):1566–72. 9.
Fairley NH, Mackie FP. Clinical and Biochemical Syndrome in
Lymphadenoma. Br Med J. 1937 Feb 20;1(3972):375-404.4. 10. O’Farrelly C,
Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, et al.
Humoral response to wheat protein in patients with coeliac disease and
enteropathy associated T cell lymphoma. Br Med J Clin Res Ed. 1986 Oct
11;293(6552):908–10. 11. Campo E, Swerdlow SH, Harris NL, Pileri S,
Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and
beyond: evolving concepts and practical applications. Blood. 2011 May
12;117(19):5019–32. 12. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe
ES, Savage KJ, et al. Enteropathy-associated T-cell lymphoma: clinical
and histological findings from the International Peripheral T-Cell
Lymphoma Project. Blood. 2011 Jul 7;118(1):148–55. 13. Zhang JC, Wang
Y, Wang XF, Zhang FX. Type I enteropathy-associated T-cell lymphoma in
the colon of a 29-year-old patient and a brief literature review.
OncoTargets Ther. 2016;9:863–8. 14. Weltgesundheitsorganisation. WHO
classification of tumours of haematopoietic and lymphoid tissues.
Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri
SA, Stein H, et al., editors. Lyon: International Agency for Research on
Cancer; 2017. 585 p. (World Health Organization classification of
tumours). 15. Ondrejka S, Jagadeesh D. Enteropathy-Associated T-Cell
Lymphoma. Curr Hematol Malig Rep. 2016 Dec;11(6):504–13. 16. Verbeek
WHM, Van De Water JMW, Al-Toma A, Oudejans JJ, Mulder CJJ, Coupé VMH.
Incidence of enteropathy - associated T-cell lymphoma: A nation-wide
study of a population-based registry in The Netherlands. Scand J
Gastroenterol. 2008 Jan;43(11):1322–8. 17. Ghimire P. Primary
gastrointestinal lymphoma. World J Gastroenterol. 2011;17(6):697. 18.
Meijer JWR, Mulder CJJ, Goerres MG, Boot H, Schweizer JJ. Coeliac
disease and (extra)intestinal T-cell lymphomas: definition, diagnosis
and treatment. Scand J Gastroenterol. 2004 Jan;39(241):78–84. 19. Gale
J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-Type
Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31
Patients in a Single Center. J Clin Oncol. 2000 Feb 14;18(4):795–795.
20. Vaidya R, Habermann TM, Donohue JH, Ristow KM, Maurer MJ, Macon WR,
et al. Bowel perforation in intestinal lymphoma: incidence and clinical
features. Ann Oncol. 2013 Sep;24(9):2439–43.